Impact of Prior Seasonal Influenza Vaccination and Infection on Pandemic A (H1N1) Influenza Virus Replication in Ferrets

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2010 Sep 16

PMID 20840835

Citations 34

Authors

A H Ellebedy

M F Ducatez

S Duan

E Stigger-Rosser

A M Rubrum

E A Govorkova

R G Webster

R J Webby

Affiliations

Soon will be listed here.

Abstract

Early epidemiologic and serologic studies have suggested pre-existing immunity to the pandemic A (H1N1) 2009 influenza virus (H1N1pdm) may be altering its morbidity and mortality in humans. To determine the role that contemporary seasonal H1N1 virus infection or trivalent inactivated vaccine (TIV) might be playing in this immunity we conducted a vaccination-challenge study in ferrets. Vaccination with TIV was unable to alter subsequent morbidity or contact transmission in ferrets following challenge with H1N1pdm. Conversely, prior infection with the contemporary seasonal H1N1 strain altered morbidity, but not transmission, of H1N1pdm despite the detection of only minimal levels of cross reactive antibodies.

Citing Articles

Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies.

Ekanger C, Dinesh Kumar N, Koutstaal R, Zhou F, Beukema M, Waldock J Front Immunol. 2025; 16:1532144.

PMID: 39981254 PMC: 11839712. DOI: 10.3389/fimmu.2025.1532144.

An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.

do Nascimento G, Bugybayeva D, Patil V, Schrock J, Yadagiri G, Renukaradhya G Viruses. 2023; 15(4).

PMID: 37112974 PMC: 10147081. DOI: 10.3390/v15040994.

Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.

Allen J, Ross T J Virol. 2022; 96(7):e0165221.

PMID: 35289635 PMC: 9006891. DOI: 10.1128/jvi.01652-21.

Animal Models Utilized for the Development of Influenza Virus Vaccines.

Kirkpatrick Roubidoux E, Schultz-Cherry S Vaccines (Basel). 2021; 9(7).

PMID: 34358203 PMC: 8310120. DOI: 10.3390/vaccines9070787.

Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.

Taghinezhad-S S, Mohseni A, Bermudez-Humaran L, Casolaro V, Cortes-Perez N, Keyvani H Vaccines (Basel). 2021; 9(5).

PMID: 34066443 PMC: 8148110. DOI: 10.3390/vaccines9050466.

References

Del Giudice G, Stittelaar K, van Amerongen G, Simon J, Osterhaus A, Stohr K . Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci Transl Med. 2010; 1(12):12re1. DOI: 10.1126/scitranslmed.3000564. View

Dawood F, Jain S, Finelli L, Shaw M, Lindstrom S, Garten R . Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360(25):2605-15. DOI: 10.1056/NEJMoa0903810. View

Hancock K, Veguilla V, Lu X, Zhong W, Butler E, Sun H . Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361(20):1945-52. DOI: 10.1056/NEJMoa0906453. View

Clark T, Pareek M, Hoschler K, Dillon H, Nicholson K, Groth N . Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009; 361(25):2424-35. DOI: 10.1056/NEJMoa0907650. View

Middleton D, Rockman S, Pearse M, Barr I, Lowther S, Klippel J . Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J Virol. 2009; 83(15):7770-8. PMC: 2708649. DOI: 10.1128/JVI.00241-09. View

Lipatov A, Hoffmann E, Salomon R, Yen H, Webster R . Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis. 2006; 194(8):1040-3. DOI: 10.1086/507709. View

Steel J, Staeheli P, Mubareka S, Garcia-Sastre A, Palese P, Lowen A . Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol. 2009; 84(1):21-6. PMC: 2798408. DOI: 10.1128/JVI.01732-09. View

Skowronski D, De Serres G, Crowcroft N, Janjua N, Boulianne N, Hottes T . Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010; 7(4):e1000258. PMC: 2850386. DOI: 10.1371/journal.pmed.1000258. View

Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

10.

Atmar R, Keitel W, Patel S, Katz J, She D, El Sahly H . Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis. 2006; 43(9):1135-42. DOI: 10.1086/508174. View

11.

Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M . In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009; 460(7258):1021-5. PMC: 2748827. DOI: 10.1038/nature08260. View

12.

Govorkova E, Webby R, Humberd J, Seiler J, Webster R . Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis. 2006; 194(2):159-67. DOI: 10.1086/505225. View

13.

De Groot A, Ardito M, McClaine E, Moise L, Martin W . Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine. 2009; 27(42):5740-7. DOI: 10.1016/j.vaccine.2009.07.040. View

14.

Echevarria-Zuno S, Mejia-Arangure J, Mar-Obeso A, Grajales-Muniz C, Robles-Perez E, Gonzalez-Leon M . Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009; 374(9707):2072-2079. DOI: 10.1016/S0140-6736(09)61638-X. View

15.

Xu R, Ekiert D, Krause J, Hai R, Crowe Jr J, Wilson I . Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science. 2010; 328(5976):357-60. PMC: 2897825. DOI: 10.1126/science.1186430. View

16.

Greenbaum J, Kotturi M, Kim Y, Oseroff C, Vaughan K, Salimi N . Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009; 106(48):20365-70. PMC: 2777968. DOI: 10.1073/pnas.0911580106. View

17.

Greenberg M, Lai M, Hartel G, Wichems C, Gittleson C, Bennet J . Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009; 361(25):2405-13. DOI: 10.1056/NEJMoa0907413. View

18.

Wei C, Boyington J, Dai K, Houser K, Pearce M, Kong W . Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med. 2010; 2(24):24ra21. PMC: 3182573. DOI: 10.1126/scitranslmed.3000799. View

19.

Maines T, Jayaraman A, Belser J, Wadford D, Pappas C, Zeng H . Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009; 325(5939):484-7. PMC: 2953552. DOI: 10.1126/science.1177238. View

20.

Kelly H, Grant K . Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill. 2009; 14(31). DOI: 10.2807/ese.14.31.19288-en. View